approved glp 1 agonists GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness New GLP-1 Guidelines for Type
Description
Pills wouldnt Weight loss drugs are going oral
The motivations differ sharply by gender
The next major M&A opportunity may involve companies with differentiated oral GLP-1 assets, GLP-1/GIP dual agonists, amylin combinations, long-acting dosing platforms, or MASH-relevant metabolic therapies
Chen J, Lin A, Luo P
Their smaller molecular structure also facilitates better tissue penetration and lower production costs, which could enhance accessibility to these novel medications
2023 Apr 7;cd230023
